Skip to main content
TipRanks
Go Ultimate75% OFF

Neuren Pharmaceuticals Limited (NURPF) Drug Pipeline

55 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Nnz-2591Phelan-Mcdermid SyndromePhase IIIRecruitingAn Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid SyndromeMar 24, 2026―
Nnz-2591Phelan-Mcdermid SyndromePhase IIIRecruitingA Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid SyndromeNov 13, 2025
Nnz-2591Prader-Willi SyndromePhase IIWithdrawnAn Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)May 18, 2023―
Nnz-2591Pitt Hopkins SyndromePhase IICompletedAn Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)Aug 24, 2021―
Nnz-2591Phelan-Mcdermid SyndromePhase IICompletedAn Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)Aug 24, 2021―
Nnz-2591Angelman SyndromePhase IICompletedAn Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman SyndromeAug 05, 2021―
Nnz-2591Healthy VolunteersPhase ICompletedTo Evaluate the Safety, Tolerability and Pharmacokinetics of Oral NNZ-2591 in Healthy VolunteersApr 30, 2020―
Nnz-2566Rett SyndromePhase IICompletedA Safety Study of NNZ-2566 in Pediatric Rett SyndromeFeb 21, 2016―
Nnz-2566ConcussionPhase IITerminatedA Safety and Efficacy Study of NNZ-2566 in Patients With Mild Traumatic Brain Injury (mTBI)Mar 19, 2014―
Nnz-2566Fragile X SyndromePhase IICompletedA Safety Study of NNZ-2566 in Patients With Fragile X SyndromeJul 03, 2013―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Neuren Pharmaceuticals Limited (NURPF) have in its pipeline
Neuren Pharmaceuticals Limited NURPF is currently developing the following drugs: Nnz-2591, Nnz-2566. These drug candidates are in various stages of clinical development as the company works toward FDA approval.